NextDocs Corporation Expands Its Operations to Europe
Provides Microsoft Office SharePoint Server-Based Document and Quality Management Solutions for Life Sciences Industry
Munich, Germany -- NextDocs Corporation <http://www.nextdocs.com/> , a leading provider of Microsoft Office SharePoint Server-based regulatory document and quality management software, announced today that is has opened a branch office in Germany. NextDocs' line of fully FDA 21 CFR Part 11 compliant SharePoint Server-based document and quality management solutions has been developed specifically for life sciences companies to enhance productivity and reduce risk.
The new office, located in Munich, will provide local sales and technical support for the European customer base. The European subsidiary will play a vital role in the global expansion of NextDocs and enable rapid growth in the European market.
"Because our main customers are based in Central Europe, the establishment of a NextDocs presence in Munich will allow us to continue our phenomenal momentum. It is a tremendous growth opportunity for our company, and it is only the first step of our fast-growing expansion in Europe. Our intention is to provide our European customer and partners with the best available local support," said NextDocs Chief Executive Officer Zikria Syed.
Rainer Schwarz has been named NextDoc's General Manager and Sales Director for the European operation.
"I am very glad to be part of NextDocs," Mr. Schwarz said. "As NextDocs moves to the next level of corporate development, the opening of this first office in Europe is an important step for our company. The demand in the life sciences market for SharePoint Server-based content management solutions continues to be enormous. Thanks to our enhanced presence on the continent, we can focus our activities in the European time zone, provide first class support and work more closely with our customers."
The European office is located in Elisabethstrasse 91, 80797 Munich, Germany.
Tel: +49 (0) 89 5908-1210 and Fax: +49 (0) 89 5908-1200
"NextDocs Document and Quality Management suite provides a comprehensive solution based on Microsoft Office SharePoint Server that allows our life sciences customers to take full advantage of their existing Microsoft technology investments, while solving key business problems," said Ruediger Dorn, Managing Director, Worldwide Pharmaceutical Industry, Microsoft Corporation. "We are happy to partner with NextDocs to roll these solutions to the European pharmaceutical community."
About NextDocs
NextDocs is a leading provider of fully FDA 21 CFR Part 11 compliant Microsoft Office SharePoint Server-based document and quality management solutions for the life sciences companies. Our mission is to deliver cost-effective, easy-to-use document management software that provides immediate productivity increases for companies operating in regulatory environments. NextDocs customers include pharmaceutical companies, bio-techs, medical device companies and CROs. For more information please visit www.nextdocs.com <http://www.nextdocs.com/> or email information@nextdocs.com.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.